StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis.

StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

[1][2] They are being studied in early stage trials.

[3][4] In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D.

to Chief Medical Officer.